Skip to Content for 2005 Annual Report Menu for 2005 Annual Report About Us Menu Research Menu Development Menu Medicines Menu Investors Menu Media Menu Careers Menu
Banner Image

2005 Annual Report

Editorial Financials

Directors, Officers and Distinguished Contributors

Board of Directors

Arthur D. Levinson, Ph.D.
Chairman and Chief Executive Officer,
Genentech

Herbert W. Boyer, Ph.D.
Co-founder of Genentech
and Professor Emeritus of Biochemistry
and Biophysics
University of California, San Francisco

William M. Burns
Chief Executive Officer of the
Pharmaceuticals Division
and Member of the Corporate
Executive Committee,
The Roche Group

Erich Hunziker, Ph.D.
Chief Financial Officer
and Member of the Corporate
Executive Committee
The Roche Group

 

Jonathan K. C. Knowles, Ph.D.
Head of Global Research
and Member of the Corporate
Executive Committee
The Roche Group

Debra L. Reed
President and Chief Operating Officer,
San Diego Gas & Electric and Southern
California Gas Company

Charles A. Sanders, M.D.
Former Chairman and Chief Executive
Officer, Glaxo, Inc.

 

Officers

Arthur D. Levinson, Ph.D.*
Chairman and Chief Executive Officer

Susan D. Desmond-Hellmann, M.D., M.P.H.*
President, Product Development

Ian T. Clark*
Executive Vice President, Commercial
Operations

David A. Ebersman*
Executive Vice President and Chief Financial
Officer

Stephen G. Juelsgaard, D.V.M., J.D.*
Executive Vice President, General Counsel,
Secretary and Chief Compliance Officer

Richard H. Scheller, Ph.D.*
Executive Vice President, Research

Patrick Y. Yang, Ph.D.*
Executive Vice President, Product Operations

Hal Barron, M.D.
Senior Vice President, Development and
Chief Medical Officer

Robert L. Garnick, Ph.D.
Senior Vice President, Regulatory,
Quality and Compliance

Marc Tessier-Lavigne, Ph.D.
Senior Vice President, Research Drug
Discovery

Vince Anicetti
Vice President, Product Portfolio
Management

Martin Babler
Vice President, Sales and Marketing,
Xolair

J. Joseph Barta
Vice President, Compliance

Ronald C. Branning
Vice President, Commercial Quality

David F. Broad, Ph.D.
Vice President and General Manager,
Oceanside Product Operations

Charles Calderaro III
Vice President, Corporate Engineering

Peter A. Carberry, M.D., M.B.A.
Vice President, Clinical Operations

Scott P. Carmer,
Vice President, Sales and Marketing,
Rituxan

Andrew C. Chan, M.D., Ph.D.
Vice President, Immunology and
Antibody Engineering

Jennifer E. Cook
Vice President, Market Development

Vishva Dixit, M.D.
Vice President, Early Discovery Research

Claudia M. Estrin
Vice President, Commercial Operations

Gwendolyn Fyfe, M.D.
Vice President, Clinical Oncology, Avastin

Markus Gemuend
Vice President, Manufacturing Collaborations

Ashraf Hanna, M.D., Ph.D.
Vice President, Alliance Management
and Pipeline Strategy Support

Roy C. Hardiman, J.D.
Vice President, Corporate Law
and Assistant Secretary

Kenneth J. Hillan, M.B., Ch.B.
Vice President, Development Sciences

Francis A. Jackson
Vice President and General Manager,
Vacaville Product Operations

 

Charles A. Johnson, M.B., Ch.B.
Vice President, Clinical, Immunology,
Tissue Growth and Repair

Sean A. Johnston, J.D., Ph.D.
Vice President, Intellectual Property
and Assistant Secretary

Pamela M. Klein, M.D.
Vice President, Clinical Oncology,
Hematology and HER Family

Ann L. Lee, Ph.D.
Vice President, Process Development

Kent E. Lieginger, Pharm.D.
Vice President, Managed Care and
Customer Operations

Karen N. McCormick
Vice President, Sales and Marketing,
Lucentis

Joseph S. McCracken, D.V.M.
Vice President, Business Development

Kevin McRaith
Vice President, Sales and Marketing,
Hematology

James P. Miller
Vice President, South San Francisco
Biochemical Manufacturing

Timothy L. Moore
Vice President, South San Francisco
Manufacturing

Walter K. Moore
Vice President, Government Affairs

Genesio Murano, Ph.D.
Vice President, Regulatory Operations

Varun Nanda
Vice President, Sales and Marketing,
Avastin

Philippa Norman
Vice President, Global Supply Chain

John Orwin
Vice President, Sales and Marketing,
BioOncology

Quinton C. Oswald
Vice President, Sales and Marketing,
Tissue Growth and Repair

Todd Pierce
Vice President, Corporate Information
Technology

John R. Pinion
Vice President, External Quality

Robert S. Quinn
Vice President, CIT Business and
Science Applications

Todd W. Rich, M.D.
Vice President, Regulatory Affairs,
Clinical and Commercial

Corsee D. Sanders, Ph.D.
Vice President, Design, Analysis,
Technology and Administration (DATA)
for Development Organization

Mary B. Sliwkowski, Ph.D.
Vice President, Regulatory Affairs,
Chemistry Manufacturing and Controls

Denise Smith-Hams
Vice President, Human Resources

Thomas T. Thomas II
Treasurer

Michael D. Varney, Ph.D.
Vice President, Small Molecule
Drug Discovery

John M. Whiting
Vice President, Controller and
Chief Accounting Officer

     
* Member of Executive Committee    

 

Staff Scientists

Avi J. Ashkenazi, Ph.D.
Research

Thomas A. Bewley, Ph.D.
Process Development

Stuart Bunting, Ph.D.
Research

Frederic de Sauvage, Ph.D.
Research

Vishva Dixit, M.D.
Research

David Giltinan, Ph.D.
Development

 

Paul Godowski, Ph.D.
Research

Peter Jackson, Ph.D.
Research

Paul Polakis, Ph.D.
Research

Steve Shire, Ph.D.
Process Development

Mark Sliwkowski, Ph.D.
Research

Richard Vandlen, Ph.D.
Research

 

Genentech Fellow

Napoleone Ferrara, M.D.
Research

 
 

 

Distinguished Engineers

Chung Hsu, Ph.D., P.E.
Process Development

Robert van Reis
Process Development

 
Bradley Wolk
Process Development

 

Distinguished Programmer Analyst

Colin Watanabe
Corporate Information Technology